Humanized Mouse and Rat Model Market to grow at 10.5% CAGR to hit $161 million by 2025– Global Insights on Size, Share, Trends, Regulatory Scenario, Expansion Plans, Key Companies, and Business Opportunities: Adroit Market Research

North America dominated the global humanized mouse and rat model market in 2018. Based on application, Oncology dominated the market in 2018.


Dallas, Texas, April 08, 2020 (GLOBE NEWSWIRE) -- The “Global Humanized Mouse and Rat Model Market Size 2018, By Type (Humanized Mouse Models, Humanized Rat Models) By Application (Oncology, Immunology and Infectious Diseases, Neuroscience, Toxicology, Hematopoiesis, Other Applications) By End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic & Research Institutions) By Region and Forecast 2019 to 2025” study provides an elaborative view of historic, present and forecasted market estimates.

Adroit Market Research report on global humanized mouse and rat model market gives a holistic view of the market from 2015 to 2025, which includes factors such as market drivers, restraints, opportunities and challenges. The market has been studied for historic years from 2015 to 2017, with the base year of estimation as 2018 and forecast from 2019 to 2025. The report covers the current status and future traits of the market at global as well as country level. In addition, the study also assesses the market based on Porter's five forces analysis and positions the key players based on their product portfolio, geographic footprint, strategic initiatives and overall revenue. Prominent players operating in the global humanized mouse and rat model market have been studied in detail.

Request a pdf sample @ https://www.adroitmarketresearch.com/contacts/request-sample/1443

The global humanized mouse and rat model market is projected to reach USD 161 million by 2025, growing at a CAGR of 10.5%. Rising demand for tailored medicine, growing number of research activities including humanized models and increasing number of R&D activities in biotechnology and pharmaceutical companies are the factors driving the growth of the humanized mouse and rat model market.

The use of laboratory animals in scientific and medical research is essential for the improvement of quality of life. Animal experiments are an integral part of understanding how basic systems of the body work, and what goes wrong with them to cause disease. They are also a necessary, and in some cases legally required, method of testing the efficacy and safety of the proposed treatments. About 28-100 million animals are experimented on and killed annually all over the globe, three fourths for medical purposes and the rest to test various products. A vast majority of medical breakthroughs have been possible because of animal-based research. Today, protection of animals is high on the agenda of most countries and sets limits on research. An increasing number of countries now have laws, regulations, or official guidance specific to animal experimentation that include work outside of research facilities and impose constraints beyond those set by general or animal welfare legislation.

Browse the full report with Table of Contents and List of Figures @ https://www.adroitmarketresearch.com/industry-reports/humanized-mouse-and-rat-model-market

The global humanized mouse and rat model market has been segmented based on type, application, and end user. By end user, the market is segmented into pharmaceutical & biotechnology companies, contract research organizations (CROs), and academic & research institutions. CROs is projected to record the highest CAGR during the forecast period.

North America was the largest market for humanized mouse and rat model in 2018, while Asia Pacific is set to register the highest CAGR during the forecast period. International alliances for R&D activities in China, research in regenerative medicine in Japan and growth of the biomedical industry in India are some of the factors fueling growth of humanized mouse and rat model market in Asia.

Key players of the humanized mouse and rat model market include Charles River Laboratories, International, Inc., The Jackson Laboratory, Taconic Biosciences, Inc., Trans Genic, Inc., Genoway, Horizon Discovery Group, Ingenious Targeting Laboratory, Crown Biosciences, Champions Oncology, HERA Biolabs, Vitalstar Biotechnology, Axenis and Harbour Antibodies among others.

Direct purchase the report @ https://www.adroitmarketresearch.com/researchreport/purchase/1443

Major points from Table of Contents:
1.    Introduction
2.    Research Methodology
3.    Market Outlook
4.    Humanized Mouse and Rat Model Market by Type, 2015-2025 (USD Million)
5.    Humanized Mouse and Rat Model Market by Application, 2015-2025 (USD Million)
6.    Humanized Mouse and Rat Model Market by End User, 2015-2025 (USD Million)
7.    Humanized Mouse and Rat Model Market by Region 2015-2025 (USD Million)
8.    Competitive Landscape
9.    Company Profiles
10.    Appendix

Access research repository of Upcoming Reports @ https://adroitmarketresearch.com/upcoming.html  

About Us:
Adroit Market Research is a global business analytics and consulting company incorporated in 2018. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a market’s size, key trends, participants and future outlook of an industry. We intend to become our clients’ knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code– Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.

Contact Us:
Ryan Johnson
Account Manager - Global
3131 McKinney Ave Ste 600
Dallas, TX 75204
Email ID: sales@adroitmarketresearch.com
Phone No.: +1 972-362 -8199
Connect with us: Facebook | Twitter | LinkedIn